| Literature DB >> 35288711 |
Kousik Kundu1,2, Manuel Tardaguila1, Alice L Mann1, Stephen Watt1, Hannes Ponstingl1, Louella Vasquez1, Dominique Von Schiller1, Nicholas W Morrell3, Oliver Stegle4,5,6, Tomi Pastinen7, Stephen J Sawcer8, Carl A Anderson1, Klaudia Walter1, Nicole Soranzo9,10,11,12,13.
Abstract
The resolution of causal genetic variants informs understanding of disease biology. We used regulatory quantitative trait loci (QTLs) from the BLUEPRINT, GTEx and eQTLGen projects to fine-map putative causal variants for 12 immune-mediated diseases. We identify 340 unique loci that colocalize with high posterior probability (≥98%) with regulatory QTLs and apply Bayesian frameworks to fine-map associations at each locus. We show that fine-mapping credible sets derived from regulatory QTLs are smaller compared to disease summary statistics. Further, they are enriched for more functionally interpretable candidate causal variants and for putatively causal insertion/deletion (INDEL) polymorphisms. Finally, we use massively parallel reporter assays to evaluate candidate causal variants at the ITGA4 locus associated with inflammatory bowel disease. Overall, our findings suggest that fine-mapping applied to disease-colocalizing regulatory QTLs can enhance the discovery of putative causal disease variants and enhance insights into the underlying causal genes and molecular mechanisms.Entities:
Mesh:
Year: 2022 PMID: 35288711 DOI: 10.1038/s41588-022-01025-y
Source DB: PubMed Journal: Nat Genet ISSN: 1061-4036 Impact factor: 41.307